Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marmé D, Schächtele C.

J Biol Chem. 1993 May 5;268(13):9194-7.

2.

Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue.

Seynaeve CM, Kazanietz MG, Blumberg PM, Sausville EA, Worland PJ.

Mol Pharmacol. 1994 Jun;45(6):1207-14.

PMID:
8022414
3.

Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.

Gekeler V, Boer R, Uberall F, Ise W, Schubert C, Utz I, Hofmann J, Sanders KH, Schächtele C, Klemm K, Grunicke H.

Br J Cancer. 1996 Sep;74(6):897-905.

4.

Selected isozymes of PKC contribute to augmented growth of fetal and neonatal bovine PA adventitial fibroblasts.

Das M, Stenmark KR, Ruff LJ, Dempsey EC.

Am J Physiol. 1997 Dec;273(6 Pt 1):L1276-84.

5.

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.

Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH 3rd, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winneroski LL, Faul MM.

J Med Chem. 1996 Jul 5;39(14):2664-71.

PMID:
8709095
6.
7.

Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed.

De Witt BJ, Kaye AD, Ibrahim IN, Bivalacqua TJ, D'Souza FM, Banister RE, Arif AS, Nossaman BD.

Am J Physiol Lung Cell Mol Physiol. 2001 Jan;280(1):L50-7.

8.

Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.

Wilkinson SE, Parker PJ, Nixon JS.

Biochem J. 1993 Sep 1;294 ( Pt 2):335-7.

9.

Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta.

Faul MM, Gillig JR, Jirousek MR, Ballas LM, Schotten T, Kahl A, Mohr M.

Bioorg Med Chem Lett. 2003 Jun 2;13(11):1857-9.

PMID:
12749884
10.

The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, et al.

J Biol Chem. 1991 Aug 25;266(24):15771-81.

11.

Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes.

Kochs G, Hummel R, Meyer D, Hug H, Marmé D, Sarre TF.

Eur J Biochem. 1993 Sep 1;216(2):597-606.

12.
13.
14.
16.

Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity.

Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH, Mushinski JF.

J Biol Chem. 1993 Mar 25;268(9):6090-6.

17.

Selective subcellular redistributions of protein kinase C isoforms by chemical hypoxia.

Huang HM, Weng CH, Ou SC, Hwang T.

J Neurosci Res. 1999 Jun 15;56(6):668-78.

PMID:
10374822
19.

UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily.

Mizuno K, Noda K, Ueda Y, Hanaki H, Saido TC, Ikuta T, Kuroki T, Tamaoki T, Hirai S, Osada S, et al.

FEBS Lett. 1995 Feb 13;359(2-3):259-61.

20.

A potential role for protein kinase C-epsilon in regulating megakaryocytic lineage commitment.

Racke FK, Wang D, Zaidi Z, Kelley J, Visvader J, Soh JW, Goldfarb AN.

J Biol Chem. 2001 Jan 5;276(1):522-8.

Items per page

Supplemental Content

Support Center